Apollo ESG NXT System, Apollo REVISE NXT System
K-Number: K232544 · 2023-09-18
Device Summary
Frequently Asked Questions
What is the Apollo ESG NXT System, Apollo REVISE NXT System?
Apollo ESG NXT System, Apollo REVISE NXT System is a medical device that received FDA 510(k) clearance on 2023-09-18. It is manufactured by Apollo Endosurgery, Inc.. The 510(k) number is K232544.
When was Apollo ESG NXT System, Apollo REVISE NXT System approved by the FDA?
Apollo ESG NXT System, Apollo REVISE NXT System received FDA 510(k) clearance on 2023-09-18, under approval number K232544.
What company makes Apollo ESG NXT System, Apollo REVISE NXT System?
Apollo ESG NXT System, Apollo REVISE NXT System is manufactured by Apollo Endosurgery, Inc..
What is the FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System?
The FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System is QTD.
Related Clinical Trials
Other Devices by Apollo Endosurgery, Inc.
Related Devices (Code: QTD)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.